Alzheimer’s disease is a notoriously difficult condition to diagnose, often only being confirmed at autopsy. The disease affects millions of people, but current tests such as PET scans and CSF samples are expensive, time-consuming, and invasive. A paradigm-shifting test for Alzheimer’s has been developed by a joint Japanese-Australian team which screens for specific biomarkers in […]